Australia, Dec. 12 -- Paradigm Biopharmaceuticals Limit (PAR) has reported gross short sales of 17,632 FPO shares on Dec. 10. The percent of issued capital of the company reported as short sales is 0.0 percent. The issued capital of the company is 349,303,603 shares.
Disclaimer: Curated by HT Syndication.
